Glucagon-like peptide-1 (GLP-1) is a weekly injectable medication that stimulates insulin release, slows gastric motility, reduces appetite, and stabilizes blood sugar
Dosing considerations after gastric bypass The standard Wegovy dosing schedule typically applies to post-bariatric patients, though your prescriber may adjust based on your individual response
Safety Concerns for Non-Diabetics: As with any medication, taking Ozempic is not without risks
Not directly, but weight loss, whether from GLP-1 medications including Wegovy, Zepbound, and their compounded forms (such as compounded semaglutide or compounded tirzepatide) or otherwise, particularly when rapid, can lead to muscle breakdown if youre not supporting your body with enough protein, amino acids, and resistance exercise